Education
About Us
Working with TipRanks
Follow Us
Ardelyx (ARDX)
NASDAQ:ARDX
ARDX Analyst Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARDX Stock 12 Month Forecast
Average Price Target
$11.11
▲(182.70%Upside)
| Highest Price Target$15.00 | Average Price Target$11.11 | Lowest Price Target$8.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$4
Hold
1.78%
Upside
Reiterated
05/17/25
Ardelyx shows strong revenue growth potential, particularly with its key products, but faces significant profitability and operational challenges. The stock's technical indicators point to a bearish trend, and its valuation metrics, particularly the negative P/E ratio, highlight ongoing financial struggles. While the earnings call was positive on growth prospects, the overall financial health and market conditions temper enthusiasm, leading to a moderate overall stock score.
Raymond James
$13→$11
Buy
179.90%
Upside
Reiterated
05/02/25
Citi
$11→$10
Buy
154.45%
Upside
Reiterated
05/02/25
BTIG
$14
Buy
256.23%
Upside
Reiterated
05/02/25
Leerink Partners
$12→$10
Buy
154.45%
Upside
Reiterated
05/02/25
Scotiabank
$15
Buy
281.68%
Upside
Reiterated
05/02/25
Unknown AnalystWedbush
Not Ranked
Wedbush
$11
Buy
179.90%
Upside
Reiterated
05/02/25
TD Cowen
$12→$10
Buy
154.45%
Upside
Reiterated
05/01/25
Piper Sandler
$8
Hold
103.56%
Upside
Reiterated
03/12/25
Ladenburg Thalmann & Co.
$13.5→$11
Buy
179.90%
Upside
Reiterated
03/07/25
H.C. Wainwright
$5.5
Hold
39.95%
Upside
Reiterated
02/20/25
Analysts Offer Insights on Healthcare Companies: Evolent Health (NYSE: EVH), Benitec Biopharma (NASDAQ: BNTC) and Ardelyx (NASDAQ: ARDX)We maintain our Neutral rating for ARDX shares as we project a low single-digit quarterly growth for XPHOZAH in 2025 while we await additional clarity on its outlook, for both near-term and long-term. Maintain Neutral with $5.50 PT.
Jefferies
$11→$8
Buy
103.56%
Upside
Reiterated
01/02/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$4
Hold
1.78%
Upside
Reiterated
05/17/25
Ardelyx shows strong revenue growth potential, particularly with its key products, but faces significant profitability and operational challenges. The stock's technical indicators point to a bearish trend, and its valuation metrics, particularly the negative P/E ratio, highlight ongoing financial struggles. While the earnings call was positive on growth prospects, the overall financial health and market conditions temper enthusiasm, leading to a moderate overall stock score.
Raymond James
$13→$11
Buy
179.90%
Upside
Reiterated
05/02/25
Citi
$11→$10
Buy
154.45%
Upside
Reiterated
05/02/25
BTIG
$14
Buy
256.23%
Upside
Reiterated
05/02/25
Leerink Partners
$12→$10
Buy
154.45%
Upside
Reiterated
05/02/25
Scotiabank
$15
Buy
281.68%
Upside
Reiterated
05/02/25
Unknown AnalystWedbush
Not Ranked
Wedbush
$11
Buy
179.90%
Upside
Reiterated
05/02/25
TD Cowen
$12→$10
Buy
154.45%
Upside
Reiterated
05/01/25
Piper Sandler
$8
Hold
103.56%
Upside
Reiterated
03/12/25
Ladenburg Thalmann & Co.
$13.5→$11
Buy
179.90%
Upside
Reiterated
03/07/25
H.C. Wainwright
$5.5
Hold
39.95%
Upside
Reiterated
02/20/25
Analysts Offer Insights on Healthcare Companies: Evolent Health (NYSE: EVH), Benitec Biopharma (NASDAQ: BNTC) and Ardelyx (NASDAQ: ARDX)We maintain our Neutral rating for ARDX shares as we project a low single-digit quarterly growth for XPHOZAH in 2025 while we await additional clarity on its outlook, for both near-term and long-term. Maintain Neutral with $5.50 PT.
Jefferies
$11→$8
Buy
103.56%
Upside
Reiterated
01/02/25
Best Analysts Covering Ardelyx
1 Month
xxx
Success Rate
10/15 ratings generated profit
Average Return
+5.01%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +5.01% per trade.
3 Months
xxx
Success Rate
7/15 ratings generated profit
Average Return
+30.05%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +30.05% per trade.
1 Year
Success Rate
7/15 ratings generated profit
Average Return
+62.68%
reiterated a buy rating last month
Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +62.68% per trade.
2 Years
xxx
Success Rate
6/15 ratings generated profit
Average Return
+82.28%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of +82.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARDX Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
May 25
Strong Buy
9
11
7
9
13
Buy
0
1
1
1
0
Hold
4
4
3
4
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
16
11
14
15
Each month's total comprises the sum of three months' worth of ratings.
ARDX Financial Forecast
ARDX Stock Forecast FAQ
What is ARDX’s average 12-month price target, according to analysts?
Based on analyst ratings, Ardelyx’s 12-month average price target is 11.11.
What is ARDX’s upside potential, based on the analysts’ average price target?
Ardelyx has 182.70% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARDX a Buy, Sell or Hold?
Ardelyx has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ardelyx’s price target?
The average price target for Ardelyx is 11.11. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $8.00. The average price target represents 182.70% Increase from the current price of $3.93.
The highest analyst price target is $15.00 ,the lowest forecast is $8.00. The average price target represents 182.70% Increase from the current price of $3.93.
What do analysts say about Ardelyx?
Ardelyx’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of ARDX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.